Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-24

FDA Approved: ARESTIN — Supplemental Application (OraPharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ARESTIN (minocycline hydrochloride) by OraPharma, Inc., indicating a regulatory change to the product label or indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARESTIN (MINOCYCLINE HYDROCHLORIDE)

Snippet

SUPPL AP for ARESTIN (MINOCYCLINE HYDROCHLORIDE)